Occult Hepatitis B Virus (HBV) Infection: a Global Challenge for Medicine

被引:20
作者
Assar, Shokrollah [1 ]
Arababadi, Mohammad Kazemi [1 ]
Ahmadabadi, Behzad Nasiri [1 ]
Salehi, Mansoor [2 ]
Kennedy, Derek [3 ]
机构
[1] Rafsanjan Univ Med Sci, Immunol Infect Dis Res Ctr, Rafsanjan, Iran
[2] Isfahan Univ Med Sci, Fac Med, Dept Genet, Esfahan, Iran
[3] Griffith Univ, Sch Biomol & Phys Sci, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia
关键词
Occult HBV infection; blood donors; post transfusion hepatitis; BLOOD-DONORS; ANTI-HBC; HEMODIALYSIS-PATIENTS; DNA; GENOTYPE; IRAN; RISK;
D O I
10.7754/Clin.Lab.2012.120119
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Hepatitis B virus (HBV) is a serious risk as a disease that can be spread through blood transfusion. Occult hepatitis B infection (OBI) is defined in a patient with the presence of HBV-DNA but a lack of HBsAg in the serum and hepatocytes. OBI can be considered as a high potential risk factor for inducing post transfusion hepatitis (PTH), hepatocellular carcinoma (HCC), cirrhosis, and reactivation of the HBV. Recently, several investigations from various regions of the world have reported PTH as well as HCC and cirrhosis among blood recipients with diseases such as thalassemia and other disorders requiring regular hemodialysis. This form of hepatitis also causes complications for individuals that are co-infected with other viruses such as HCV and HIV. Because of its extreme disease potential, OBI can be considered a high risk for PTH, HCC, and cirrhosis. Therefore, an understanding of the prevalence of OBI among blood donors is a critical strategy in most transfusion services. This review addresses the recent information regarding the prevalence of OBI worldwide, with an additional focus on Iranian blood donors. (Clin. Lab. 2012;58:1225-1230. DOI: 10.7754/Clin.Lab.2012.120119)
引用
收藏
页码:1225 / 1230
页数:6
相关论文
共 51 条
[1]   Occult Hepatitis B Virus Infection in Hemodialysis Patients With Isolated Hepatitis B Core Antibody: A Multicenter Study [J].
Aghakhani, Arezoo ;
Banifazl, Mohammad ;
Kalantar, Ebrahim ;
Eslamifar, Ali ;
Ahmadi, Farrokhlagha ;
Razeghi, Effat ;
Atabak, Shahnaz ;
Amini, Manouchehr ;
Khadem-Sadegh, Akbar ;
Ramezani, Amitis .
THERAPEUTIC APHERESIS AND DIALYSIS, 2010, 14 (03) :349-353
[2]   Characterization of Occult Hepatitis B Virus Strains in South African Blood Donors [J].
Allain, Jean-Pierre ;
Belkhiri, Dalila ;
Vermeulen, Marion ;
Crookes, Robert ;
Cable, Russell ;
Amiri, Azin ;
Reddy, Ravi ;
Bird, Arthur ;
Candotti, Daniel .
HEPATOLOGY, 2009, 49 (06) :1868-1876
[3]   Occult hepatitis B virus infection: implications in transfusion [J].
Allain, JP .
VOX SANGUINIS, 2004, 86 (02) :83-91
[4]  
Allain JP, 2012, BIOLOGICALS, V2012, P1
[5]   Occult B Infection in the Brazilian Northeastern Region: A Preliminary Report [J].
Almeida, Delvone ;
Tavares-Neto, Jose ;
Trepo, Christian ;
Almeida, Alessandro ;
Mello, Caroline ;
Chemin, Isabelle ;
Parana, Raymundo .
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (04) :310-312
[6]  
Amini K, 2004, BLOOD J, V3, P379
[7]  
Arababadi MK, 2011, HEPAT MON
[8]  
Arababadi MK, 2011, CLIN LAB
[9]   Non-association of IL-12+1188 and IFN-γ+874 polymorphisms with cytokines serum level in occult HBV infected patients [J].
Arababadi, Mohammad K. ;
Pourfathollah, Ali A. ;
Jafarzadeh, Abdollah ;
Hassanshahi, Gholamhossein ;
Daneshmandi, Saeed ;
Shamsizadeh, Ali ;
Kennedy, Derek .
SAUDI JOURNAL OF GASTROENTEROLOGY, 2011, 17 (01) :30-35
[10]  
Arababadi MK, 2009, SAUDI J KIDNEY DIS T, V20, P398